Treating complex, multifactorial diseases is one of the top challenges in clinical practice today. Like many other chronic diseases that burden the healthcare system, multiple signaling pathways are ...
Ryan Haumschild, PharmD, MS, MBA: Let’s talk about clinical pathways. We’ve seen pathways continue to emerge. One good thing about pathways is they ensure a high standard of care for all patients.
Targeting the estrogen receptor and HER2 pathways improved progression-free survival in patients with HR-positive, HER2-positive metastatic breast cancer. Findings from a recent clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback